Nomad Foods Ltd current report, Q1 FY2019

Business Context and Reporting Period

This Form 6-K filing by Nomad Foods Ltd, dated March 20, 2019, reports on the pricing of an underwritten public offering of ordinary shares. The Company is a foreign private issuer filing under Rule 13a-16 of the Securities Exchange Act of 1934.

Key Financial Metrics

The filing details a capital raise rather than operational financial results. Key figures include:

  • Shares Offered: 17,391,305 ordinary shares.
  • Offering Price: $20.00 per share.
  • Gross Proceeds: Approximately $347.8 million (before underwriting discounts and expenses).
  • Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 2,608,695 additional shares.
  • Expected Closing Date: On or about March 22, 2019.

The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.

Material Changes

The primary material event is the execution of an underwriting agreement with Goldman Sachs & Co. LLC on March 19, 2019. This represents a significant change in the Company's capital structure pending the closing of the transaction.

Guidance, Outlook, and Risks

Use of Proceeds: Net proceeds are intended for general corporate purposes.
Lock-Up Agreement: The Company and certain executive officers and directors agreed not to sell or dispose of ordinary shares for 90 days following March 19, 2019, without written consent from the representative underwriter.
Risks and Contingencies: The closing is subject to the satisfaction of various customary conditions. The Company has agreed to indemnify underwriters against certain liabilities under the Securities Act of 1933.

Investor Verification Checklist

  • Verify the final closing date of the offering and the actual net proceeds received after deducting underwriting discounts and offering expenses.
  • Confirm whether the underwriters exercised the 30-day option to purchase the additional 2,608,695 shares.
  • Review the full Underwriting Agreement (Exhibit 1.1) for specific representations, warranties, and termination provisions.
  • Monitor subsequent filings for the allocation of net proceeds to specific corporate purposes.